$PAYX

UBS maintains Neutral on Paychex, lowers target to $98

Paychex reported Q4 2026 revenue of $1.6B, up 12% YoY, and full-year revenue of $6.5B, up 17%. Fiscal 2027 guidance projects 5-6% revenue growth and 7-9% EPS growth. UBS maintained a Neutral rating, lowering the price target to $98, citing a cleaner fiscal 2027 setup.

Original reporting
Published Sep 19, 2026, 1:36 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 19, 2026, 1:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
UBS maintains Neutral on Paychex, lowers target to $98 — source image
Decision brief

The 30-second read

$PAYXNeutralMed
01

Why it matters

Earnings beat on revenue and EPS, but guidance is modest; market likely to price in neutral stance.

02

Market read

Primary earnings disclosure for a mid‑cap U.S. payroll services firm; relevant for traders focused on earnings momentum and sector exposure.

03

What to watch

AI engine WISE rollout could drive higher margin expansion than reflected in guidance.

Relevance 8/10Novelty 8/10Timing: post‑earnings release

Background

Paychex reported FY2026 results and FY2027 outlook, highlighting integration of the Paycor acquisition and launch of an AI engine.

Company-level read

Ticker impact

$PAYXNeutralHigh confidence
Context

Q4 FY2026 revenue rose 12% YoY to $1.6B, EPS $1.17, and the company issued FY2027 guidance of 5‑6% revenue growth and 7‑9% EPS growth.

Expected impact

Potential short‑term upside if market digests better‑than‑expected earnings, but limited upside on modest guidance.

Evidence & confidence

The earnings numbers are fresh and material for a mid‑cap payroll services firm; guidance sets expectations for the next fiscal year, likely keeping the stock range‑bound.

Market effects

Payroll and HR services sector may see modest re‑rating as Paychex signals steady growth.

U.S. large‑cap payroll services market impact limited to Paychex and peers.

Low global relevance; primarily U.S. investors.

Counterpoint

Guidance may be too conservative; upside potential if synergies from Paycor integration accelerate faster.

Key entities

  • Paychex Inc

    Payroll and HR services provider (ticker PAYX).

  • Guggenheim Securities

    Maintains Neutral rating on Paychex.

Related articles

$PAYXMedAI 8/10

Paychex Inc (PAYX) Stock News & Articles

Paychex (PAYX) reported Q3 earnings, beating estimates with $1.295 billion in revenue and year-over-year growth. The company pays a 3.65% dividend, raised for 14 consecutive years, despite adding $4.2 billion in debt. Analysts have recently covered PAYX in broader research calls.

$UNPMed

This Union Pacific Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Ulta Beauty (NASDAQ:ULT

Analysts upgraded several companies: Needham upgraded Similarweb (SMWB) to Buy with a $11 target, Wolfe Research upgraded Paychex (PAYX) to Peer Perform, Needham upgraded Rocket Pharmaceuticals (RCKT) to Buy with a $9 target, UBS upgraded Union Pacific (UNP) to Buy with a $339 target, and Barclays upgraded Alvotech (ALVO) to Overweight with a $8 target.

$INTUMedAI 8/10

Finance and HR Software Stocks Q2 Recap: Benchmarking Marqeta (NASDAQ:MQ)

Intuit (INTU) reported $4.35B revenue (up 13.7% YoY), beating expectations, but lowered full-year guidance, causing its stock to fall 10.1%. BILL (BILL) reported $436.2M revenue (up 13.8% YoY), beating expectations, but missed full-year revenue guidance. Paychex (PAYX) reported $1.61B revenue (up 12.5% YoY), meeting expectations, and its stock rose 18.2%.

$PCTYMedAI 8/10

HR Software Stocks Q2 Teardown: Paylocity (NASDAQ:PCTY) Vs The Rest

Paylocity (PCTY) reported Q2 revenue of $444.7M, up 11% YoY, beating estimates by 3.1%. Paycom (PAYC) saw revenue of $531.2M, up 9.8%, outperforming by 3.5%. Asure Software (ASUR) grew 23.2% to $37.11M but missed billings estimates. Paychex (PAYX) reported $1.61B, up 12.5%, meeting expectations. Group revenues beat consensus by 1.7%, with shares up 10.4% on average post-earnings.